Meeting Coverage:

Glaucoma 360 New Horizons Forum

Glaucoma 360: 2017

FDA Perspective on the Field of Glaucoma

Show Description +

Richard Lewis, MD, provides an overview of a panel discussion with representatives from the FDA's Center for Devices and Radiological Health and from the Division of Transplant and Ophthalmology Products in the Center for Drug Evaluation and Research. Dr. Lewis reflects on some of the successes and challenges.

Posted: 2/03/2017

Up Next

MIGS: Where We Are and Where We're Going

Steven Vold, MD, Thomas Samuelson, MD


Venture Capital's Transformative Role in Glaucoma

Emmett Cunningham Jr, MD, PhD, MPH, Steven Vold, MD

Telemedicine and Artificial Intelligence in Glaucoma

Lama Al-Aswad, MD, MPH, Steven Vold, MD

FDA Perspective on the Field of Glaucoma

Richard Lewis, MD, provides an overview of a panel discussion with representatives from the FDA's Center for Devices and Radiological Health and from the Division of Transplant and Ophthalmology Products in the Center for Drug Evaluation and Research. Dr. Lewis reflects on some of the successes and challenges.

Posted: 2/03/2017


Please log in to leave a comment.

More From Glaucoma 360: 2017 Coverage

MIGS: Where We Are and Where We're Going

Steven Vold, MD, Thomas Samuelson, MD

Venture Capital's Transformative Role in Glaucoma

Emmett Cunningham Jr, MD, PhD, MPH, Steven Vold, MD

Telemedicine and Artificial Intelligence in Glaucoma

Lama Al-Aswad, MD, MPH, Steven Vold, MD